DEEP VEIN THROMBOSIS PANEL DVT PANEL Test
Test Cost: AED 3040.0
Symptoms: Deep vein thrombosis (DVT) is a condition in which blood clots form in the deep veins of the body, typically in the legs.
Diagnosis: The DVT panel test is a diagnostic tool used to assess the risk of DVT or confirm its presence. The panel includes several tests that can help identify individuals at risk or confirm the presence of DVT.
Test Components:
- Antithrombin Activity Functional
- Cardiolipin Antibodies IgG and IgM
- dRVVT
- Protein C Functional
- Protein S antigen, Free
Price: AED 3040.0
Sample Condition: 2 mL (1 mL min.) serum from 1 SST and 6 mL whole blood in 2 Blue Top (Sodium Citrate) tubes. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 mins. & finally transfer the supernatant (PPP) to 1 labelled, clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory.
Report Delivery: Sample daily by 3 pm; Report next day
Method: Electromechanical Clot Detection, EIA, Immunoturbidimetry, Chromogenic
Test Type: Disorders of Coagulation
Doctor: Hematologist
Test Department: COAGULATION
Pre Test Information: Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory. It is recommended that the patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician.
Test Details:
The DVT panel test is a diagnostic tool used to assess the risk of deep vein thrombosis (DVT), a condition in which blood clots form in the deep veins of the body, typically in the legs. The panel includes several tests that can help identify individuals at risk or confirm the presence of DVT.
The tests included in the DVT panel may vary depending on the healthcare provider or laboratory, but common tests may include:
- D-dimer test: This blood test measures the levels of a substance called D-dimer, which is released when a blood clot breaks down. Elevated D-dimer levels may indicate the presence of a blood clot, but further testing is usually required for confirmation.
- Complete blood count (CBC): This test provides information about the number and types of blood cells in the body. Abnormalities in blood cell counts may suggest an increased risk of blood clotting.
- Prothrombin time (PT) and international normalized ratio (INR): These tests measure the time it takes for blood to clot. They are commonly used to monitor the effectiveness of anticoagulant medications, such as warfarin, in preventing blood clots.
- Activated partial thromboplastin time (aPTT): This test evaluates the time it takes for blood to clot in response to certain substances. It is often used to monitor the effectiveness of heparin, another type of anticoagulant medication.
- Factor V Leiden mutation test: This genetic test checks for a specific mutation in the Factor V gene, which can increase the risk of blood clots, including DVT.
- Antithrombin III activity test: This test measures the levels of antithrombin III, a protein that helps regulate blood clotting. Low levels of antithrombin III can increase the risk of blood clots.
These tests, when used together, provide a comprehensive assessment of an individual’s risk of DVT or help in the diagnosis of the condition. It is important to consult with a healthcare provider to determine which tests are appropriate based on individual circumstances.
Test Name | DEEP VEIN THROMBOSIS PANEL DVT PANEL Test |
---|---|
Components | *Antithrombin Activity Functional *Cardiolipin Antibodies IgG and IgM *dRVVT *Protein C Functional * Protein S antigen, Free |
Price | 3040.0 AED |
Sample Condition | 2 mL (1 mL min.) serum from 1 SST AND6 mL whole blood in 2 Blue Top (Sodium Citrate) tubes. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible make PPP within 1 hour of collection as follows:Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 mins. & finally transfer the supernatant (PPP) to 1 labelled, clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred.Duly filled Coagulation Requisition Form (Form 15) is mandatory. |
Report Delivery | Sample Daily by 3 pm; ReportNextday |
Method | ElectromechanicalClot Detection, EIA, Immunoturbidimetry, Chromogenic |
Test type | Disorders of Coagulation |
Doctor | Hematologist |
Test Department: | COAGULATION |
Pre Test Information | Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory. It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. |
Test Details |
The DVT panel test is a diagnostic tool used to assess the risk of deep vein thrombosis (DVT), a condition in which blood clots form in the deep veins of the body, typically in the legs. The panel includes several tests that can help identify individuals at risk or confirm the presence of DVT. The tests included in the DVT panel may vary depending on the healthcare provider or laboratory, but common tests may include: 1. D-dimer test: This blood test measures the levels of a substance called D-dimer, which is released when a blood clot breaks down. Elevated D-dimer levels may indicate the presence of a blood clot, but further testing is usually required for confirmation. 2. Complete blood count (CBC): This test provides information about the number and types of blood cells in the body. Abnormalities in blood cell counts may suggest an increased risk of blood clotting. 3. Prothrombin time (PT) and international normalized ratio (INR): These tests measure the time it takes for blood to clot. They are commonly used to monitor the effectiveness of anticoagulant medications, such as warfarin, in preventing blood clots. 4. Activated partial thromboplastin time (aPTT): This test evaluates the time it takes for blood to clot in response to certain substances. It is often used to monitor the effectiveness of heparin, another type of anticoagulant medication. 5. Factor V Leiden mutation test: This genetic test checks for a specific mutation in the Factor V gene, which can increase the risk of blood clots, including DVT. 6. Antithrombin III activity test: This test measures the levels of antithrombin III, a protein that helps regulate blood clotting. Low levels of antithrombin III can increase the risk of blood clots. These tests, when used together, provide a comprehensive assessment of an individual’s risk of DVT or help in the diagnosis of the condition. It is important to consult with a healthcare provider to determine which tests are appropriate based on individual circumstances. |